These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7775944)
1. Measles antibodies in women and infants in the vaccine era. Kacica MA; Venezia RA; Miller J; Hughes PA; Lepow ML J Med Virol; 1995 Feb; 45(2):227-9. PubMed ID: 7775944 [TBL] [Abstract][Full Text] [Related]
2. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581 [TBL] [Abstract][Full Text] [Related]
3. Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers. Kumar ML; Johnson CE; Chui LW; Whitwell JK; Staehle B; Nalin D Vaccine; 1998 Dec; 16(20):2047-51. PubMed ID: 9796063 [TBL] [Abstract][Full Text] [Related]
4. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers. Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978 [TBL] [Abstract][Full Text] [Related]
5. Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants. Johnson CE; Darbari A; Darbari DS; Nalin D; Whitwell J; Chui LW; Cleves MA; Kumar ML Vaccine; 2000 May; 18(22):2411-5. PubMed ID: 10738098 [TBL] [Abstract][Full Text] [Related]
6. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Maldonado YA; Lawrence EC; DeHovitz R; Hartzell H; Albrecht P Pediatrics; 1995 Sep; 96(3 Pt 1):447-50. PubMed ID: 7651776 [TBL] [Abstract][Full Text] [Related]
7. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review. Guerra FM; Crowcroft NS; Friedman L; Deeks SL; Halperin SA; Severini A; Hatchette TF; Bolotin S; Vaccine; 2018 Feb; 36(10):1248-1255. PubMed ID: 29398276 [TBL] [Abstract][Full Text] [Related]
8. Immunity against measles in populations of women and infants in Poland. Janaszek W; Slusarczyk J Vaccine; 2003 Jun; 21(21-22):2948-53. PubMed ID: 12798638 [TBL] [Abstract][Full Text] [Related]
9. Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement. Gonçalves G; Cutts F; Forsey T; Andrade HR Rev Inst Med Trop Sao Paulo; 1999; 41(1):21-6. PubMed ID: 10436666 [TBL] [Abstract][Full Text] [Related]
10. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe. Obi CL; Tswana SA; Moyo SR; Berejena C Cent Afr J Med; 1996 May; 42(5):135-8. PubMed ID: 8771931 [TBL] [Abstract][Full Text] [Related]
11. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224 [TBL] [Abstract][Full Text] [Related]
12. Optimal age for vaccination against measles in the State of São Paulo, Brazil, taking into account the mother's serostatus. Zanetta RA; Amaku M; Azevedo RS; Zanetta DM; Burattini MN; Massad E Vaccine; 2001 Oct; 20(1-2):226-34. PubMed ID: 11567768 [TBL] [Abstract][Full Text] [Related]
13. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants. Pabst HF; Spady DW; Carson MM; Krezolek MP; Barreto L; Wittes RC Vaccine; 1999 Apr; 17(15-16):1910-8. PubMed ID: 10217589 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Protective Measles Virus Antibody Levels in Umbilical Cord Blood Samples and Sera of Mothers and Transplacental Transport Ratio in Turkey. Cetin Coban S; Temel F; Duman P; Cosgun Y; Ozarslan F; Kayman T; Guven S; Bezirganoglu H; Gunes O; Yilmaz Ciftdogan D; Karadagli EE; Kaya C; Kara A Jpn J Infect Dis; 2019 May; 72(3):185-192. PubMed ID: 30700655 [TBL] [Abstract][Full Text] [Related]
15. Measles elimination: old and new challenges? Muller CP Vaccine; 2001 Mar; 19(17-19):2258-61. PubMed ID: 11257344 [TBL] [Abstract][Full Text] [Related]
16. [Transplacental measles immunity in infants in the 1st year of life]. Bystriakova LV; Zaĭtseva RV; Kolobova LV; Pushkareva EA; Smorodinova IP Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):50-2. PubMed ID: 1839342 [TBL] [Abstract][Full Text] [Related]
17. The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants. Altintaş DU; Evliyaoğlu N; Kilinç B; Sen'an DI; Güneşer S Eur J Epidemiol; 1996 Dec; 12(6):647-8. PubMed ID: 8982627 [TBL] [Abstract][Full Text] [Related]
18. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel. Dagan R; Slater PE; Duvdevani P; Golubev N; Mendelson E Pediatr Infect Dis J; 1995 Nov; 14(11):965-9. PubMed ID: 8584363 [TBL] [Abstract][Full Text] [Related]
19. A comparison of alternate immunization regimes for measles in vaccinated populations. Pabst HF; Boothe PM; Carson MM Vaccine; 1999 Jan; 17(2):182-92. PubMed ID: 9987153 [TBL] [Abstract][Full Text] [Related]
20. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination. Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À; Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]